All Articles on Drugs
Which prescription drug policies control patient costs?Americans worry about medication and health care costs. Dr. Kai Yeung studies policies and laws to reduce them.
Alcohol and drug use care goes virtual with COVID-19Kaiser Permanente Washington researcher Joe Glass advises integrating digital prescriptions into existing care.
Could ‘deprescribing’ anticholinergic drugs prevent dementia?Dr. Larson reflects on splashes, ripples, and new research, which builds on his earlier findings from the ACT study.
Finding safer ways to treat behavioral disorders in kids and teensWith $10 million from NIMH, KPWHRI is leading a multi-site study to ensure safe prescribing of antipsychotic drugs for youth with behavioral disorders.
Our top 6 reasons why ‘it was a very good year’See how 2015 was the Institute’s best year yet—for funding and practical impact, improving people’s health at Group Health and across the country.
What if you’re taking an anticholinergic medication?Study coauthors Drs. Sascha Dublin, Shelly Gray, and Eric B. Larson explore how to balance the risks and benefits of these common medications.
Anticholinergic drugs linked to risk for pneumonia in elderlyGroup Health study suggests higher risk with acute or chronic use.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.